Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug Library Screening

CONCLUSION: CSF3R participates in the occurrence and development of OS bone destruction by regulating the inflammatory response of osteoblasts and osteoclasts and can affect the survival prognosis of OS patients.PMID:37877147 | DOI:10.2174/0115748928259095231010055507

Source: Recent Patents on Anti-Cancer Drug Discovery - October 25, 2023 Category: Cancer & Oncology Authors: Qian Li Jinlu Shan Wei Duan Yu Chen Source Type: research